However, our findings suggest a disconnect between c-Myc expression and DDX18 levels in lung cancer, highlighting the possibility of cell type-specific regulatory mechanisms or the existence of alternative upstream regulators of DDX18. This evidence concerns the gene MYC and lung carcinoma.